Transcriptomics and Proteomics in the Study of H1N1 2009

Genomics, Proteomics and Bioinformatics

Volumn 8, Issue 3, 2010, Pages 139-144

  Zhang, Lijun ^a,b   Zhang, Xiaojun ^c   Ma, Qing ^d   Ma, Fang ^b   Zhou, Honghao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUZHOU GENERAL HOSPITAL   (China)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

H1N1; Host; Proteomics; Transcriptomics

Indexed keywords

ANTIVIRUS AGENT; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN M2; RNA; SMALL INTERFERING RNA;

ANTIVIRAL ACTIVITY; DISEASE TRANSMISSION; ELECTROSPRAY MASS SPECTROMETRY; GENE SEQUENCE; GENE THERAPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HIGH THROUGHPUT SCREENING; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MASS SPECTROMETRY; MICROARRAY ANALYSIS; PANDEMIC; POINT OF CARE TESTING; PROGNOSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; RNA PROCESSING; TRANSCRIPTOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; DISEASE OUTBREAKS; GENE EXPRESSION PROFILING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEOME; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA INTERFERENCE;

INFLUENZA A VIRUS; SUIDAE;

EID: 77958127151     PISSN: 16720229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1672-0229(10)60016-2     Document Type: Review

References (31)

1. Centers for Disease Control and Prevention (CDC) Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. Morb. Mortal. Wkly. Rep. 2009, 58:400-402.
2. Gallaher W.R. Towards a sane and rational approach to management of Influenza H1N1 2009. Virol. J. 2009, 6:51.
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009, 360:2605-2615.
4. Cohen J. Pandemic influenza. Straight from the pig's mouth: swine research with swine influenzas. Science 2009, 325:140-141.
5. Peiris J.S., et al. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J. Clin. Virol. 2009, 45:169-173.
6. ECDC Technical Emergency Team Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveill. 2009, 14:19204.
7. Baras B., et al. A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses. Influenza Other Respi. Viruses 2008, 2:251-260.
8. Kash J.C. Applications of high-throughput genomics to antiviral research: evasion of antiviral responses and activation of inflammation during fulminant RNA virus infection. Antiviral Res. 2009, 83:10-20.
9. Fornek J.L., et al. Use of functional genomics to understand influenza-host interactions. Adv. Virus Res. 2007, 70:81-100.
10. Lu Q., et al. Detection in 2009 of the swine origin influenza A (H1N1) virus by a subtyping microarray. J. Clin. Microbiol. 2009, 47:3060-3061.
11. Shapira S.D., et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139:1255-1267.
12. Liu N., et al. Mutations in influenza virus replication and transcription: detection of amino acid substitutions in hemagglutinin of an avian influenza virus (H1N1). FASEB J. 2009, 23:3377-3382.
13. Morrissey B., Downard K.M. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry. Proteomics 2006, 6:2034-2041.
14. Poon L.L., et al. Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays. Clin. Chem. 2009, 55:1555-1558.
15. Pabbaraju K., et al. Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J. Clin. Microbiol. 2009, 47:3454-3460.
16. Ellis J.S., Zambon M.C. Molecular diagnosis of influenza. Rev. Med. Virol. 2002, 12:375-389.
17. Weinberg A. Evaluation of three influenza A and B rapid antigen detection kits-update. Clin. Diagn. Lab. Immunol. 2005, 12:1010.
18. Huang Y., et al. Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J. Clin. Microbiol. 2009, 47:390-396.
19. Childs R.A., et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 2009, 27:797-799.
20. Karlas A., et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
21. Zhou Y., et al. Transgenic plant-derived siRNAs can suppress propagation of influenza virus in mammalian cells. FEBS Lett. 2004, 577:345-350.
22. Sui H.Y., et al. Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. PLoS One 2009, 4:e5671.
23. Zhou H., et al. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice. Antiviral Res. 2007, 76:186-193.
24. Li W., et al. Differential suppressive effect of promyelocytic leukemia protein on the replication of different subtypes/strains of influenza A virus. Biochem. Biophys. Res. Commun. 2009, 389:84-89.
25. Gooskens J., et al. Morbidity and mortality associated with nosocomial transmission of osel-tamivir-resistant influenza A (H1N1) virus. JAMA 2009, 301:1042-1046.
26. Patriarca P.A. New options for prevention and control of influenza. JAMA 1999, 282:75-77.
27. Vester D., et al. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics 2009, 9:3316-3327.
28. Antonov A.V., et al. PPI spider: a tool for the interpretation of proteomics data in the context of protein-protein interaction networks. Proteomics 2009, 9:2740-2749.
29. Wahl A., et al. HLA class I molecules reflect an altered host proteome after influenza virus infection. Hum. Immunol. 2010, 71:14-22.
30. Ohman T., et al. Actin and RIG-I/MAVS signaling components translocate to mitochondria upon influenza A virus infection of human primary macrophages. J. Immunol. 2009, 182:5682-5692.
31. Jensen L.J., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009, 37:D412-D416.